RBC Lysis Buffer (10X)

Pricing & Availability
Other Names
Red blood cell lysis buffer
Ave. Rating
5 reviews
Product Citations
publications
Cat # Size Price Quantity Avail. Save
420301 100 ml $55.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Red Blood Cell (RBC) Lysis Buffer has been designed, formulated, and tested to ensure optimal lysis of RBCs in single cell suspensions with minimal effects on leukocytes. RBC Lysis Buffer is supplied as a 10X solution containing ammonium chloride, potassium carbonate, and EDTA, and should be diluted in deionized water prior to use. Nucleated RBCs are not effectively lysed with ammonium chloride.

Product Details
Technical data sheet

Product Details

Formulation
This red blood cell (RBC) lysis buffer is supplied as a 10X solution and should be diluted to 1X in deionized water. 100 ml of 10X concentrate will yield a quantity of 1X solution that is sufficient to lyse 500 samples.
Preparation
The pH of the 1X solution should fall within the range of pH 7.1-7.4. Adjust the pH if necessary. Warm the 1X solution to room temperature prior to use.
Storage & Handling
Store RBC lysis buffer between 2°C and 8°C.
Application

FC, ICFC - Quality tested

Application Notes

A. Lysis of Mouse Spleen RBCs:
1. Harvest mouse spleen and prepare a single cell suspension.
2. Pellet the cells by centrifugation (350 x g); aspirate the supernatant.
3. Dilute the 10X Red Blood Cell Lysis Buffer to 1X working concentration with deionized water and resuspend the pellet in 5 ml of 1X Lysis Buffer.
4. Incubate on ice for 4-5 minutes with occasional shaking.
5. Stop the reaction by diluting the Lysis Buffer with 20-30 ml of 1X PBS.
6. Spin the cells (350 x g) and discard the supernatant.
7. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer Cat. No. 420201), wash 1X.
8. Count cells, adjust density, and proceed with cell staining procedures.
B. Lysis of Human Peripheral Blood RBCs:
1. Dilute the 10X RBC Lysis Buffer to 1X working concentration with deionized water. Warm the 1X solution to room temperature prior to use.
2. Add 2.0 ml of 1X RBC Lysis Buffer to each tube containing up to 100 µl of whole blood.
3. Gently vortex each tube immediately after adding the lysing solution. Incubate at room temperature, protected from light, for 10-15 minutes.
4. Centrifuge 350 x g for 5 minutes. Aspirate supernatant without disturbing pellet.
5. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer, Cat. No. 420201), wash 1X.
6. Resuspend and proceed with further procedures.

Application References

(PubMed link indicates BioLegend citation)
  1. Adams RA, et al. 2007. J. Exp. Med. 204:571.
  2. Feild-Corbett C, et al. 2009. Stem Cells. PubMed
  3. de Resende MM, et al. 2010. Physiol Genomics. 42:437. PubMed
  4. Roybal JD, et al. 2011. Mol Cancer Res. 9:25. PubMed
  5. Boldin MP, et al. 2011. J Exp Med. PubMed
  6. Kahlenberg JM, et al. 2011. J. Immunol. 187:6143. PubMed
  7. Deiuliis JA, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:399. PubMed
  8. Wu CY, et al. 2012. PLoS One. 7:e42365. PubMed
  9. Hsia BJ, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  10. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  11. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. PubMed
  12. Saraiva AM, 2013. Hum Immunol. 74:207. PubMed
  13. Koon HW, et al. 2013. J Vis exp. 68:4208. PubMed
  14. Ma Dy, et al. 2013. J Virol. 87:3361. PubMed
  15. Han W, 2013. J. Immunol. 190:4786. PubMed
  16. Garcia-Acros I, et al. 2013. J Biol Chem. 288:14046. PubMed
  17. Zhao JL, et al. 2013. Elife. 21:537. PubMed
  18. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. PubMed
  19. Yamasaki S, et al. 2013. Clin Vaccine immunol. 20:1508. PubMed
  20. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  21. Liu X, et al. 2013. Invest Ophthalmol Vis Sci. 54:7386. PubMed
  22. Fullerton AM, et al. 2013. Toxicol Sci. 136:72. PubMed
  23. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  24. Varga T, et al. 2013. J. Immunol. 191:5695. PubMed
  25. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  26. Chang YJ, et al. 2014. Cytotherapy. 16:560. PubMed
  27. Kim MJ, et al. 2014. Mol Pharmacol. 86:284. PubMed
  28. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  29. Szulzewsky F, et al. 2015. PloS One. 10:116644. PubMed
Product Citations
  1. Field-Corbett C, et al. 2009. Stem Cells. 27:662. PubMed
  2. Resende M, et al. 2010. Physiol Genomics. 42:437. PubMed
  3. Kahlenberg J, et al. 2011. J Immunol. 187:6143. PubMed
  4. Boldin M, et al. 2011. J Exp Med. 208:1189. PubMed
  5. Roybal J, et al. 2011. Mol Cancer Res. 9:25. PubMed
  6. Denning W, et al. 2011. PLoS One. 6:e16897. PubMed
  7. Deiuliis J, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:L399. PubMed
  8. Wu C, et al. 2012. PLoS One. 7:e42363. PubMed
  9. Hsia B, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  10. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  11. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. . PubMed
  12. Saraiva A, et al. 2013. Hum Immunol. 74:207. PubMed
  13. Ma D, et al. 2013. J Virol. 87:3361. PubMed
  14. Han W, et al. 2013. J Immunol. 190:4786. PubMed
  15. Garcia-Arcos I, et al. 2013. J Biol Chem. 288:14046. PubMed
  16. Zhao J, et al. 2013. Elife. 21:537. PubMed
  17. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. . PubMed
  18. Yamasaki S, et al. 2013. Clin Vaccine Immunol. 20:1508. PubMed
  19. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  20. Liu X, et al. 2013. Invest Ophthalmol Vis Sci . 54:7386. PubMed
  21. Sci T 2013. Toxicol Sci. 136:72. PubMed
  22. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  23. Varga T, et al. 2013. J Immunol. 191:5695. PubMed
  24. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  25. Chang Y, et al. 2014. Cytotherapy. 16:560. PubMed
  26. Kim M, et al. 2014. Mol Pharmacol. 86:284. PubMed
  27. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  28. Szulzewsky F, et al. 2015. PLoS One. 10:116644. PubMed
  29. Birnie K, et al. 2015. Mol Cancer Res. 13: 1106 - 1118. PubMed
  30. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  31. Magalhães L, et al. 2015. PLoS Negl Trop Dis. 10: 0003816. PubMed
  32. Fujii H, et al. 2015. PLoS One. 10: 0133216. PubMed
  33. Weber G, et al. 2015. Surgery. 158: 248-254. PubMed
  34. YC S, SJ L 2015. Sci Rep. 5: 12578. PubMed
  35. Hamour S, et al. 2015. PLoS One. 10: 0136238. PubMed
  36. Ilievski V, et al. 2015. PLoS One. 10: 0136502. PubMed
  37. Hou J, et al. 2015. J Mol Cell Biol. 7: 338-350. PubMed
  38. Koon H, et al. 2012. J Vis Exp. 68: 4208. PubMed
  39. Facchini M, et al. 2014. J Vis Exp. 85: 51019. PubMed
  40. Song C, et al. 2015. Blood. 126: 1813 - 1822. PubMed
  41. Liu Y, et al. 2015. Sci Rep. 5: 15134. PubMed
  42. Jaiswal M, et al. 2015. Sci Rep. 5: 15221. PubMed
  43. Durward-Diioia M, et al. 2015. Infect Immun . 83: 4759 - 4771. PubMed
  44. Ensan S, et al. 2015. Nat Immunol. 17: 159-168. PubMed
  45. Bazett M, Haston M 2016. Sci Rep. 6:19189. PubMed
  46. Fukui R, et al. 2016. J Immunol. 196: 416 - 427. PubMed
  47. St-Pierre S, et al. 2016. PLoS One. 11: 0150230. PubMed
  48. Mohammed R, et al. 2016. Cell Rep. 14:760-771. PubMed
  49. Pankova D, et al. 2016. Mol Cancer Res. 14: 287 - 295. PubMed
  50. Samuelson D, et al. 2016. J Immunol. 196: 2655 - 2665. PubMed
  51. Muñoz-Ruiz M, et al. 2016. Nat Immunol. 10.1038/ni.3424. PubMed
  52. Hodson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 2039-2046. PubMed
  53. Bosma M, et al. 2016. Nat Commun. 7: 11314. PubMed
  54. Barros-Martins J, et al. 2016. J Immunol. 196: 3642 - 3652. PubMed
  55. Zheng M, et al. 2016. J Immunol. 196: 4122 - 4131. PubMed
  56. Moraes-Vieira P, et al. 2016. Diabetes. 65: 1317 - 1327. PubMed
  57. Pennington L, et al. 2016. Nat Commun. 7:11610. PubMed
  58. Tsao P, et al. 2016. Proc Natl Acad Sci U S A. 113: 8242 - 8247. PubMed
  59. Munson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 8272 - 8277. PubMed
  60. Mircheff A, et al. 2016. Ocul Surf. 14:460-483. PubMed
  61. Theurl I, et al. 2016. Nat Med. 10.1038/nm.4146. PubMed
  62. Now H, Yoo J 2016. Cell Mol Immunol. 10.1038/cmi.2016.32. PubMed
  63. Jiang H, et al. 2016. Nat Med. 10.1038/nm.4123. PubMed
  64. Rodriguez-Garcia M, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.72. PubMed
  65. Agrawal V, et al. 2016. J Leukoc Biol. 100: 261 - 274. PubMed
  66. Metz H, et al. 2016. Proc Natl Acad Sci U S A. 113: 8795 - 8800. PubMed
  67. Lizotte P, et al. 2016. Sci Rep. 6:31745. PubMed
  68. Pridans C, et al. 2016. J Immunol. 197: 2297 - 2305. PubMed
  69. Sauter K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G533 - G547. PubMed
  70. Luo B, et al. 2016. J Neurosci. 36: 9590 - 9603. PubMed
  71. Soncini M, et al. 2016. Proc Natl Acad Sci U S A. 113: E6219 - E6227. PubMed
  72. Yu H, et al. 2016. Sci Rep. 6:35190. PubMed
  73. Spengler J, et al. 2016. J Infect Dis. 214: S308 - S318. PubMed
  74. Yang C, et al. 2016. Sci Rep. 6:34643. PubMed
  75. Elgueta R, et al. 2016. J Immunol. 197: 3970 - 3981. PubMed
  76. Wang X, et al. 2016. J Virol. 90: 10247 - 10258. PubMed
  77. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  78. Brunmeir R, et al. 2016. PLoS Genet. 12:e1006474. PubMed
  79. Shen X, et al. 2016. Sci Rep. 6:38778. PubMed
  80. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  81. Canali S, et al. 2017. Blood. 129(4):405-414. PubMed
  82. Nowyhed H, et al. 2017. Sci Rep. 7:40273. PubMed
  83. Morris C, et al. 2017. MBio. 10.1128/mBio.00036-17. PubMed
  84. Elisabeth Schrumpf, Xiaojun Jiang 2017. Physiol Rep. 10.14814/phy2.13117. PubMed
  85. Ubellacker J, et al. 2017. Breast Cancer Res. 10.1186/s13058-017-0815-8. PubMed
  86. Ramaswamy G, et al. 2017. Sci Rep. 10.1038/srep45140. PubMed
  87. Jiang S, et al. 2017. Toxicology Lett. 10.1016/j.toxlet.2017.03.015. PubMed
  88. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  89. Rentsendorj A, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.08.019. PubMed
  90. Wang K, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.016. PubMed
  91. Zhang Z, et al. 2017. Journal of Translational Medicine. 10.1186/s12967-017-1196-6. PubMed
  92. Liu W, et al. 2017. Int J Environ Res Public Health. 10.3390/ijerph14060592. PubMed
  93. Kim M, et al. 2017. Int J Mol Sci. 10.3390/ijms18061275. PubMed
  94. Wen J, et al. 2017. J Hematol Oncol. 10.1186/s13045-017-0489-9. PubMed
  95. Wong C, et al. 2017. J Immunol. 10.4049/jimmunol.1700397. PubMed
  96. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  97. Samuelson D, et al. 2017. PLoS Pathogens. 13(6):e1006426. PubMed
  98. Elphinstone R, et al. 2017. Infect Immun. 10.1128/IAI.00371-17. PubMed
  99. Weaver J, et al. 2017. Part Fibre Toxicol. 10.1186/s12989-017-0206-4. PubMed
  100. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  101. Mochizuki M,et al. 2017. J Am Heart Assoc. . 10.1161/JAHA.117.005920. PubMed
  102. Ahmad S,et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. . 10.1016/j.pnpbp.2017.10.001. PubMed
  103. Bichsel C, et al. 2017. Sci Rep. 10.1038/s41598-017-09928-1. PubMed
  104. Bowers J, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01221. PubMed
Publication Library

Antigen Details

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 07/23/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 9727 Pacific Heights Blvd, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Login/Register
Forgot your password? Reset Password
Request an Account